These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28903572)

  • 1. Biomarkers in Immunoglobulin Light Chain Amyloidosis.
    Kufová Z; Sevcikova T; Growkova K; Vojta P; Filipová J; Adam Z; Pour L; Penka M; Rysava R; Němec P; Brozova L; Vychytilova P; Jurczyszyn A; Grosicki S; Barchnicka A; Hajdúch M; Simicek M; Hájek R
    Klin Onkol; 2017; 30(Supplementum2):60-67. PubMed ID: 28903572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
    Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
    Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AL amyloidosis with a localized B cell neoplasia.
    Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
    Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidogenic light chains impair plasma cell survival.
    Pick M; Lebel E; Elgavish S; Benyamini H; Nevo Y; Hertz R; Bar-Tana J; Rognoni P; Merlini G; Gatt ME
    Haematologica; 2023 Dec; 108(12):3359-3371. PubMed ID: 37381778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview.
    Kryukov F; Kryukova E; Brozova L; Kufova Z; Filipova J; Growkova K; Sevcikova T; Jarkovsky J; Hajek R
    Gene; 2016 Oct; 591(2):490-8. PubMed ID: 27288311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.
    Wang Y; Xu L; Liu Y; Hu Y; Shi Q; Jin L; Yang L; Wang P; Zhang K; Huang X; Ge Q; Lu J
    Int J Hematol; 2021 Feb; 113(2):231-242. PubMed ID: 33040275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis.
    Chen EC; Rubinstein S; Soto C; Bombardi RG; Day SB; Myers L; Zaytsev A; Majedi M; Cornell RF; Crowe JE
    PLoS One; 2020; 15(7):e0235713. PubMed ID: 32634163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.
    Paiva B; Martinez-Lopez J; Corchete LA; Sanchez-Vega B; Rapado I; Puig N; Barrio S; Sanchez ML; Alignani D; Lasa M; García de Coca A; Pardal E; Oriol A; Garcia ME; Escalante F; González-López TJ; Palomera L; Alonso J; Prosper F; Orfao A; Vidriales MB; Mateos MV; Lahuerta JJ; Gutierrez NC; San Miguel JF
    Blood; 2016 Jun; 127(24):3035-9. PubMed ID: 27069257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin light chain amyloid aggregation.
    Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
    Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional assay to identify amyloidogenic light chains.
    Martin EB; Williams AD; Heidel RE; Foster JS; Lands RH; Kennel SJ; Wall JS
    Amyloid; 2018 Jun; 25(2):93-100. PubMed ID: 29571269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
    Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
    Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
    Bianchi G; Kumar S
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the management of AL Amyloidosis.
    Kastritis E; Dimopoulos MA
    Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development.
    Alameda D; Goicoechea I; Vicari M; Arriazu E; Nevone A; Rodriguez S; Lasa M; Puig N; Cedena MT; Alignani D; Garate S; Lara-Astiaso D; Vilas-Zornoza A; Sarvide S; Ocio EM; Lecumberri R; Garcia de Coca A; Labrador J; Gonzalez ME; Palomera L; Gironella M; Cabañas V; Casanova M; Oriol A; Krsnik I; Perez-Montaña A; de la Rubia J; de la Puerta JE; de Arriba F; Fazio VM; Martinez-Lopez J; Lahuerta JJ; Mateos MV; Odero MD; Prosper F; Weiner A; Amit I; Nuvolone M; San Miguel JF; Paiva B
    Blood; 2021 Oct; 138(17):1583-1589. PubMed ID: 34133718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?
    Zhang C; Huang X; Li J
    Blood Rev; 2017 Jul; 31(4):261-270. PubMed ID: 28336182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival.
    Huang XF; Jian S; Lu JL; Shen KN; Feng J; Zhang CL; Tian Z; Wang JL; Lei WJ; Cao XX; Zhou DB; Liang ZY; Li J
    Amyloid; 2020 Mar; 27(1):36-44. PubMed ID: 31635489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Light chain amyloidosis].
    Hegenbart U; Aus dem Siepen F; Schönland S
    Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
    Bhutani D; Leng S; Lentzsch S
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):555-559. PubMed ID: 31262668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.